Cybin Inc (CYBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYBN | AMGN | VRTX | REGN | BMY |
| Company | Cybin Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.3700 | 301.75 | 406.42 | 967.88 | 43.98 |
| High | 0.3720 | 302.91 | 415.67 | 970.56 | 44.26 |
| Low | 0.3600 | 298.51 | 394.03 | 957.10 | 43.84 |
| Last | 0.3690 | 300.30 | 410.24 | 969.97 | 44.04 |
| Change | +0.0010 | +0.82 | +7.74 | +11.33 | +0.14 |
| % Change | +0.27% | +0.27% | +1.92% | +1.18% | +0.32% |
| Volume | 2,020,650 | 2,436,425 | 1,604,085 | 357,021 | 10,900,071 |
| 20-Day Average Volume | 3,252,308 | 2,787,199 | 1,085,624 | 516,088 | 14,216,436 |
| Previous Close | 0.3680 | 299.48 | 402.50 | 958.64 | 43.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3627 | 275.29 | 398.61 | 912.03 | 46.72 |
| 20-Day Raw Stochastic | 27.71% | 64.23% | 76.36% | 98.92% | 7.76% |
| 20-Day Relative Strength | 45.35% | 63.11% | 54.19% | 61.40% | 29.35% |
| Weighted Alpha | -23.86 | +28.21 | +17.80 | +30.20 | -36.28 |
| Today's Opinion | 88% Sell | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 40% Buy | 24% Sell | 24% Buy | 56% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.86% since 04/30/24 | +9.68% since 04/30/24 | +4.34% since 04/30/24 | +8.56% since 04/30/24 | +0.02% since 04/30/24 |
| Low | 0.3370 on 05/01/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 43.33 on 05/02/24 |
| High | 0.3798 on 05/06/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | -13.27% since 04/05/24 | +11.30% since 04/05/24 | +0.78% since 04/05/24 | +2.56% since 04/05/24 | -14.36% since 04/05/24 |
| Low | 0.3370 on 05/01/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.4355 on 04/08/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +20.00% since 02/07/24 | +1.55% since 02/07/24 | -2.20% since 02/07/24 | +3.03% since 02/07/24 | -9.64% since 02/07/24 |
| Low | 0.2926 on 02/08/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 0.5224 on 03/13/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -34.07% since 11/07/23 | +10.82% since 11/07/23 | +8.35% since 11/07/23 | +16.38% since 11/07/23 | -15.95% since 11/07/23 |
| Low | 0.2831 on 02/07/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 0.5700 on 11/28/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 151,195 | 160,633,888 | 104,029,752 | 105,222,248 | 88,989,688 |
| Shares Outstanding, K | 410,855 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -35,930,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -22,270,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.50 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 02/14/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 06/25/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 29.84 | 25.79 | 41.90 |